AI Startup Suki Secures $90M in Series E Funding

Suki, a Redwood City, CA-based company that specializes in ambient clinical intelligence (ACI), has raised $90 million in a Series E financing round.

The round was led by new investors Healthier Capital, Crosslink Capital, and Hercules Capital, with participation from all existing institutional investors, including Venrock, Flare Capital Partners, Hedosophia, Philips Ventures, and Zoom Ventures.

The company will use the funding to accelerate growth, advance its healthcare AI technology, improve integrations, and expand its commercial team.

What is Suki?

Suki develops AI technology that helps healthcare professionals reduce administrative work and manage clinical workflows.

Read More:Tamr Raises $21M in Funding Led by Volition Capital

Its platform, built around ambient clinical intelligence (ACI), converts clinical conversations into useful information for documentation, medical coding, revenue cycle management, and clinical reasoning.

Suki works with electronic health record (EHR) systems and supports different medical specialties and care settings. Its technology helps clinicians spend less time on paperwork while supporting healthcare organisations in improving clinical and financial performance.

The company has also expanded beyond clinical documentation into operational workflows and clinical knowledge. Its Ask feature brings clinical knowledge from Wolters Kluwer’s UpToDate Expert AI directly into clinicians’ workflows.

How Much Funding Has Suki Raised?

Suki has raised $90 million in its latest Series E funding round.

The source does not provide details of previous funding rounds or the company's total funding raised to date.

Who Invested in Suki’s Series E?

The Series E round was led by three new investors:

• Healthier Capital
• Crosslink Capital
• Hercules Capital

Existing institutional investors also participated in the round:

• Venrock
• Flare Capital Partners
• Hedosophia
• Philips Ventures
• Zoom Ventures

As part of the financing, Aman Mahajan, MD, PhD, MBA, a partner at Healthier Capital, will join Suki’s Board of Directors. Mahajan has previously held roles at UPMC and UCLA Health.

Why the Funding Matters

Suki will use the funding to accelerate business growth, advance its healthcare AI technology ecosystem, improve integrations, and expand its commercial organisation.

The investment will also support the company's efforts to connect healthcare AI tools across clinical, financial, and operational workflows. Suki aims to make its technology available through partnerships with companies that embed its AI into their own platforms or provide complementary data and intelligence.

Who founded Suki?

Suki was founded in 2017 by Punit Soni. The company is headquartered in Redwood City, California.

“Clinical documentation was never the destination. It was the entry point,” said Punit Soni, Founder and CEO of Suki. “Healthcare doesn’t need another collection of disconnected AI features. It needs an intelligent operating system that understands the patient, works across the health system, and can help clinicians and organizations get work done.

“The real opportunity for AI in healthcare isn't to automate individual tasks. It's to rethink how work gets done across the health system,” said Aman Mahajan, MD, PhD, MBA, Partner at Healthier Capital. “What makes Suki particularly compelling is its dual approach: delivering AI directly to clinicians through its own application, Suki for Clinicians, while also powering AI capabilities within the platforms, and technologies healthcare organizations already use.

Market and Business Growth

Suki reported strong growth in the adoption of its healthcare AI platform.

Key business metrics include:

• Healthcare organisations: More than 450.
• Technology partners: More than 30 companies embed Suki's AI into their platforms.
• Patient encounters: Encounters supported by Suki grew more than 190% year over year in 2026.
• Revenue: Revenue doubled in 2025, with the company on track for similar growth in 2026.
• Partner business: Revenue from its partner business increased more than tenfold over the past two years.
• Financial impact: KLAS-validated results show an average monthly financial impact of more than $2,600 per provider.

The company has expanded its product capabilities beyond documentation to include clinical reasoning, coding, revenue cycle management, and operational workflows.

What Happens Next?

Suki plans to use the new funding to expand its healthcare AI ecosystem, improve its technology, strengthen integrations, and grow its commercial team.

The company will also continue working with technology partners to connect AI capabilities across healthcare platforms and workflows.

Read More:California-Based Reach Security Raises Over $50M in Series B Funding